Virtual Medicinal Product (VMP)
-
Testosterone 50mg/5g transdermal gel unit dose tube
Name Details
|
Current Name
Testosterone 50mg/5g transdermal gel unit dose tube
|
Start Date
01-11-2023
|
End Date
|
|
Previous Name
Testosterone 50mg/5g gel unit dose tube
|
Start Date
30-07-2015
|
End Date
31-10-2023
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tube
- Unit Dose UOM
- tube
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 4 (CD Anab)
- Route
- Transdermal
- Form
- Transdermal gel
- Ontology Form/Route
- gel.transdermal
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G03BA03
| BNF |
|
Current BNF
06040200
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
06040200
|
Start Date
03-11-2005
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 9186611000001108 |
12-04-2005 |
|
VMP Ingredients
VMP ingredients table
| Testosterone |
Based on Ingredient Substance |
|
50 mg |
|
Name
Testosterone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Testosterone
-
VMP
(Current) Testosterone 50mg/5g transdermal gel...
Virtual Medicinal Product Pack (VMPP) Information